Richa Pant

Dr. Richa Pant

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
PAPranav Ajmera
Pranav Ajmera
AKAmit Kharat
Amit Kharat
JSJitesh Seth
Jitesh Seth
SRSnehal Rathi
Snehal Rathi
RPRicha Pant
Richa Pant
SKSanjay Khaladkar
Sanjay Khaladkar
Background: Computed tomographic pulmonary angiography (CTPA) is the diagnostic standard for confirming pulmonary embolism (PE). Since PE is a life-threatening condition, early diagnosis and treatment are critical to avoid PE-associated morbidity and mortality. However, PE remains subject to misdiagnosis. Methods: We retrospectively identified 251 CTPAs performed at a tertiary care hospital between January 2018 to January 2021. The scans were classified as positive (n = 55) and negative (n = 196) for PE based on the annotations made by board-certified radiologists. A fully anonymized CT slice served as input for the detection of PE by the 2D segmentation model comprising U-Net architecture with Xception encoder. The diagnostic performance of the model was calculated at both the scan and the slice levels. Results: The model correctly identified 44 out of 55 scans as positive for PE and 146 out of 196 scans as negative for PE with a sensitivity of 0.80 [95% CI 0.68, 0.89], a specificity of 0.74 [95% CI 0.68, 0.80], and an accuracy of 0.76 [95% CI 0.70, 0.81]. On slice level, 4817 out of 5183 slices were marked as positive for the presence of emboli with a specificity of 0.89 [95% CI 0.88, 0.89], a sensitivity of 0.93 [95% CI 0.92, 0.94], and an accuracy of 0.89 [95% CI 0.887, 0.890]. The model also achieved an AUROC of 0.85 [0.78, 0.90] and 0.94 [0.936, 0.941] at scan level and slice level, respectively for the detection of PE. Conclusion: The development of an AI model and its use for the identification of pulmonary embolism will support healthcare workers by reducing the rate of missed findings and minimizing the time required to screen the scans.

7 December 2022 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
SGSuraj Ghuwalewala
Suraj Ghuwalewala
VKViraj Kulkarni
Viraj Kulkarni
RPRicha Pant
Richa Pant
AKAmit Kharat
Amit Kharat
Radiology, being one of the younger disciplines of medicine with a history of just over a century, has witnessed tremendous technological advancements and has revolutionized the way we practice medicine today. In the last few decades, medical imaging modalities have generated seismic amounts of medical data. The development and adoption of artificial intelligence applications using this data will lead to the next phase of evolution in radiology. It will include automating laborious manual tasks such as annotations, report generation, etc, along with the initial radiological assessment of patients and imaging features to aid radiologists in their diagnostic and treatment planning workflow. We propose a level-wise classification for the progression of automation in radiology, explaining artificial intelligence assistance at each level with the corresponding challenges and solutions. We hope that such discussions can help us address challenges in a structured way and take the necessary steps to ensure the smooth adoption of new technologies in radiology.

2 February 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
PAPranav Ajmera
Pranav Ajmera
POPrashant Onkar
Prashant Onkar
SDSanjay Desai
Sanjay Desai
RPRicha Pant
Richa Pant
JSJitesh Seth
Jitesh Seth
VKV. M. Kulkarni
V. M. Kulkarni
Purpose: Manual interpretation of chest radiographs is a challenging task and is prone to errors. An automated system capable of categorizing chest radiographs based on the pathologies identified could aid in the timely and efficient diagnosis of chest pathologies. Method: For this retrospective study, 4476 chest radiographs were collected between January and April 2021 from two tertiary care hospitals. Three expert radiologists established the ground truth, and all radiographs were analyzed using a deep-learning AI model to detect suspicious ROIs in the lungs, pleura, and cardiac regions. Three test readers (different from the radiologists who established the ground truth) independently reviewed all radiographs in two sessions (unaided and AI-aided mode) with a washout period of one month. Results: The model demonstrated an aggregate AUROC of 91.2% and a sensitivity of 88.4% in detecting suspicious ROIs in the lungs, pleura, and cardiac regions. These results outperform unaided human readers, who achieved an aggregate AUROC of 84.2% and sensitivity of 74.5% for the same task. When using AI, the aided readers obtained an aggregate AUROC of 87.9% and a sensitivity of 85.1%. The average time taken by the test readers to read a chest radiograph decreased by 21% (p < 0.01) when using AI. Conclusion: The model outperformed all three human readers and demonstrated high AUROC and sensitivity across two independent datasets. When compared to unaided interpretations, AI-aided interpretations were associated with significant improvements in reader performance and chest radiograph interpretation time.

23 June 2022 in medRxiv
Verified
Preprint
Open access
PDF file
PAPranav Ajmera
Pranav Ajmera
RPRicha Pant
Richa Pant
JSJitesh Seth
Jitesh Seth
SGSuraj Ghuwalewala
Suraj Ghuwalewala
SKSahil Kathuria
Sahil Kathuria
AKAmit Kharat
Amit Kharat
Objective: To assess a deep learning-based artificial intelligence model for the detection of pulmonary nodules on chest radiographs and to compare its performance with board-certified human readers. Methods: For this retrospective study, 308 chest radiographs were obtained between January 2019 to December 2021 from a tertiary care hospital. All radiographs were analyzed using a deep learning AI model called DxNodule AI Screen. Two expert board-certified radiologists established the ground truth, and 11 test readers independently reviewed all radiographs in two sessions (unaided and AI-aided mode) with a washout period of one month. Results: The standalone model had an AUROC of 0.905 [0.87, 0.94] in detecting pulmonary nodules. The mean AUROC across the 11 readers improved from 0.798 [0.74, 0.86] for unaided interpretation to 0.846 [0.82, 0.880] for AI-aided interpretation. With DxNodule AI Screen, readers were able to identify nodules at the correct locations, which they otherwise missed. The mean specificity, accuracy, PPV, and NPV of the readers improved significantly from 0.87 [0.78, 0.96], 0.78 [0.72, 0.84], 0.77 [0.65, 0.88], and 0.86 [0.81, 0.90] in the unaided session to 0.89 [0.82, 0.96], 0.83 [0.80, 0.85], 0.82 [0.73, 0.9], and 0.89 [0.86, 0.92], respectively in the aided session. Conclusion: DxNodule AI Screen outperformed human readers in nodule detection performance on chest radiographs, and enhanced human readers’ performances when used as an aid.

1 August 2022 in Research Square
Verified
Preprint
Open access
PDF file
PAPranav Ajmera
Pranav Ajmera
RPRicha Pant
Richa Pant
JSJitesh Seth
Jitesh Seth
SGSuraj Ghuwalewala
Suraj Ghuwalewala
SKSahil Kathuria
Sahil Kathuria
AKAmit Kharat
Amit Kharat
Background Most early lung cancers appear as pulmonary nodules on medical imaging, however, radiologists frequently overlook these on chest radiographs. We assessed if a deep learning-based artificial intelligence model can help detect pulmonary nodules on chest radiographs and compared its performance with board-certified human readers. Methods For this retrospective study, 308 chest radiographs were obtained between January 2019 to December 2021 from a tertiary care hospital. All radiographs were analyzed using a deep learning AI model called DxNodule AI Screen. Two expert board-certified radiologists established the ground truth, and 11 test readers independently reviewed all radiographs in two sessions (unaided and AI-aided mode) with a washout period of one month. Results The standalone model had an AUROC of 0.905 [0.87, 0.94] in detecting pulmonary nodules. The mean AUROC across the 11 readers improved from 0.798 [0.74, 0.86] for unaided interpretation to 0.846 [0.82, 0.880] for AI-aided interpretation. With DxNodule AI Screen, readers were able to identify nodules at the correct locations, which they otherwise missed. The mean specificity, accuracy, PPV, and NPV of the readers improved significantly from 0.87 [0.78, 0.96], 0.78 [0.72, 0.84], 0.77 [0.65, 0.88], and 0.86 [0.81, 0.90] in the unaided session to 0.89 [0.82, 0.96], 0.83 [0.80, 0.85], 0.82 [0.73, 0.9], and 0.89 [0.86, 0.92], respectively in the aided session. Conclusion DxNodule AI Screen outperformed human readers in nodule detection performance on chest radiographs, and enhanced human readers’ performances when used as an aid.

23 September 2021 in medRxiv
Verified
Preprint
Open access
PDF file
ANAvinash Nanivadekar
Avinash Nanivadekar
Kapil Gangadhar ZirpeKapil Gangadhar Zirpe
Kapil Gangadhar Zirpe
ADAshutosh Dwivedi
Ashutosh Dwivedi
RPRajan Patel
Rajan Patel
RPRicha Pant
Richa Pant
AKAmit Kharat
Amit Kharat
Background Early prediction of disease severity in COVID-19 patients is essential. Chest X-ray (CXR) is a faster, widely available, and less expensive imaging modality that may be useful in predicting mortality in COVID-19 patients. Artificial Intelligence (AI) may help expedite CXR reading times, and improve mortality prediction. We sought to develop and assess an artificial intelligence system that used chest X-rays and clinical parameters to predict mortality in COVID-19 patients. Methods A retrospective study was conducted in Ruby Hall Clinic, Pune, India. The study included patients who had a positive real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test for COVID-19 and at least one available chest X-ray at the time of their initial presentation or admission. Features from CXR images and clinical parameters were used to train the Random Forest model. Results Clinical data from a total of 201 patients was assessed retrospectively. The average age of the cohort was 51.4±14.8 years, with 29.4% of the patients being over the age of 60. The model, which used CXRs and clinical parameters as inputs, had a sensitivity of 0.83 [95% CI: 0.7, 0.95] and a specificity of 0.7 [95% CI: 0.64, 0.77]. The area under the curve (AUC) on receiver operating characteristics (ROC) was increased from 0.74 [95% CI: 0.67, 0.8] to 0.79 [95% CI: 0.72, 0.85] when the model included features of CXRs in addition to clinical parameters. Conclusion An Artificial Intelligence (AI) model based on CXRs and clinical parameters demonstrated high sensitivity and can be used as a rapid and reliable tool for COVID-19 mortality prediction.